Comparison of recurrence of low risk superficial bladder cancer in patients with and without single dose intravesical doxorubicin instillation

ABSTRACT

Introduction: Urinary bladder Cancer [UC] is second most common cancer among patients with genitourinary malignancies. Because of high recurrence rate the patients with Non-muscle-invasive bladder cancer [NMIBC] requires a lifelong surveillance. Doxorubicin has been shown to decrease recurrence rate on long term follow up. However, evidence on its efficacy on short term follow-up is limited. The purpose of the current study was to find out early recurrence rate after Doxorubicin treatment. If found low, this study will reduce the costs and hospital burden for patients needing Re-TURBT